Dennis H. Langer's Insider Trades & SAST Disclosures
Dennis H. Langer's most recent trade in Quoin Pharmaceuticals Ltd - ADR was a trade of 50,714 Share Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 9, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Dennis H. Langer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd ... | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 50,714 | 50,714 | - | - | Share Option (Right to Buy) | |
| Quoin Pharmaceuticals Ltd ... | Dennis H. Langer | Director | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 07 Jun 2024 | 297 | 53 | - | 0.7 | 217 | Ordinary Shares |
| Myriad Genetics, Inc. | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,275 | 106,802 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Dennis H. Langer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 30,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Myriad Genetics, Inc. | Dennis H. Langer | Director | Sale of securities on an exchange or to another person at price $ 34.75 per share. | 03 Aug 2021 | 30,000 | 89,527 (0%) | 0% | 34.8 | 1,042,500 | Common Stock |
| Myriad Genetics, Inc. | Dennis H. Langer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.39 per share. | 03 Aug 2021 | 30,000 | 119,527 (0%) | 0% | 25.4 | 761,700 | Common Stock |
| Myriad Genetics, Inc. | Dennis H. Langer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 12,848 | 89,527 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges